Azora Therapeutics, Inc. (DE) AZR
NASDAQ AZR
$4.09 +0.35 (+9.36%)
At close: Nov 13, 2026 · 4:00 PM EST

Azora Therapeutics, Inc. (DE) (AZR) Cash from Financing Activities (2017 - 2026)

Updated

Azora Therapeutics, Inc. (DE)'s Cash from Financing Activities came in at -$35,000 for Q3 2026, compared with $525,000 a year earlier.

Analysis

Azora Therapeutics, Inc. (DE) (AZR) Cash from Financing Activities (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Azora Therapeutics, Inc. (DE) reported Cash from Financing Activities of $28.09 million, up 378.2% year-over-year; for FY2025, it was $8.47 million, up 8.0% from FY2024.

  • Cash from Financing Activities carries a five-year compound annual growth rate of 8.6% (FY2020 to FY2025).
  • Going back by year, Cash from Financing Activities was $7.85 million in FY2024 (+89.9%), $4.13 million in FY2023 (-54.7%), $9.13 million in FY2022 (-33.1%) and $13.64 million in FY2021 (+143.3%).
  • The Q3 2026 figure represents the lowest quarterly Cash from Financing Activities in data going back to Q3 2017.
  • Year-over-year, Cash from Financing Activities increased in two of the last four quarters, with growth averaging 178.5%.
  • The fastest year-over-year change in Cash from Financing Activities over five years came in Q1 2024 (growth of 527.3%), and the weakest in Q2 2022 (a decline of 99.9%).
  • Business Quant data shows AZR's Cash from Financing Activities at $25.21 million (Q2 2026), $315,284 (Q1 2026) and $2.6 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -7.22 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -8.53 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 6.82 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -2.43 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 6.63 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -4.39 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -1.53 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -2.51 Bn
10 Azora Therapeutics, Inc. (DE) 58.43 Mn -2.79 Mn - -35,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -35,000.00
Jun 30, 2026 25.21 Mn
Mar 31, 2026 315,284.00
Dec 31, 2025 2.60 Mn
Sep 30, 2025 524,801.00
Jun 30, 2025 5.30 Mn
Mar 31, 2025 50,648.00
Sep 30, 2024 3.61 Mn
Jun 30, 2024 411,091.00
Mar 31, 2024 3.82 Mn
Dec 31, 2023 3.38 Mn
Sep 30, 2023 138,669.00
Jun 30, 2023 58.00
Mar 31, 2023 609,613.00
Jun 30, 2022 1,865.00
Mar 31, 2022 9.12 Mn
Dec 31, 2021 1.25 Mn
Sep 30, 2021 5.50 Mn
Jun 30, 2021 2.81 Mn
Mar 31, 2021 4.08 Mn
API Access

Azora Therapeutics, Inc. (DE) Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=AZR&period=max&api_key=YOUR_API_KEY